Cargando…

Analysis of Relationships between DAT1 Polymorphism Variants, Personality Dimensions, and Anxiety in New Psychoactive Substance (Designer Drug) (NPS) Users

The use of ‘new psychoactive substances’ appears to be increasingly common. The aim of this study was to examine biological and personality determinants in individuals who choose to use these substances, which may help in the prevention and treatment of psychoactive substance use disorders. The stud...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chmielowiec, Jolanta, Chmielowiec, Krzysztof, Masiak, Jolanta, Pawłowski, Tomasz, Larysz, Dariusz, Grzywacz, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8700894/ https://www.ncbi.nlm.nih.gov/pubmed/34946924 http://dx.doi.org/10.3390/genes12121977

Ejemplares similares

DRD4, DRD2, DAT1, and ANKK1 Genes Polymorphisms in Patients with Dual Diagnosis of Polysubstance Addictions
por: Masiak, Jolanta, et al.
Publicado: (2020)

Association of Polymorphism within the Putative miRNA Target Site in the 3′UTR Region of the DRD2 Gene with Neuroticism in Patients with Substance Use Disorder
por: Boroń, Agnieszka, et al.
Publicado: (2022)

DNA Methylation of the Dopamine Transporter DAT1 Gene—Bliss Seekers in the Light of Epigenetics
por: Chmielowiec, Krzysztof, et al.
Publicado: (2023)

Associations between the COMT rs4680 Gene Polymorphism and Personality Dimensions and Anxiety in Patients with a Diagnosis of Other Stimulants Dependence
por: Chmielowiec, Krzysztof, et al.
Publicado: (2022)

Influence of DAT1 Promotor Methylation on Sports Performance
por: Grzywacz, Anna, et al.
Publicado: (2021)

Associations Between Physical Effort and DNA Methylation in the Promotor Region of the Dopamine Transporter Gene (DAT1)
por: Michałowska-Sawczyn, Monika, et al.
Publicado: (2021)

Epigenetic Analysis of the Dopamine Transporter Gene DAT1 with a Focus on Personality Traits in Athletes
por: Humińska-Lisowska, Kinga, et al.
Publicado: (2023)

Associations Between the Dopamine D4 Receptor and DAT1 Dopamine Transporter Genes Polymorphisms and Personality Traits in Addicted Patients
por: Chmielowiec, Jolanta, et al.
Publicado: (2018)

DRD4 Exon 3 Gene Polymorphisms in Patients Diagnosed with Polysubstance Use Disorder and Co-Occurrence of a Depressive Episode
por: Chmielowiec, Krzysztof, et al.
Publicado: (2021)

Analysis of Polymorphic Variants of the Dopamine Transporter (DAT1) Gene Polymorphism and Personality Traits Among Athletes
por: Michałowska-Sawczyn, Monika, et al.
Publicado: (2020)

Association between Polymorphism rs1799732 of DRD2 Dopamine Receptor Gene and Personality Traits among Cannabis Dependency
por: Chmielowiec, Jolanta, et al.
Publicado: (2022)

Associations of Brain-Derived Neurotropic Factor rs6265 Gene Polymorphism with Personality Dimensions among Athletes
por: Humińska-Lisowska, Kinga, et al.
Publicado: (2022)

Personality Traits or Genetic Determinants—Which Strongly Influences E-Cigarette Users?
por: Grzywacz, Anna, et al.
Publicado: (2020)

Association of the rs3864283 Polymorphism Located in the HINT1 Gene with Cigarette Use and Personality Traits
por: Suchanecka, Aleksandra, et al.
Publicado: (2023)

Serotonin Receptor HTR3A Gene Polymorphisms rs1985242 and rs1062613, E-Cigarette Use and Personality
por: Suchanecka, Aleksandra, et al.
Publicado: (2022)

Vitamin D Receptor Gene Polymorphisms and Cigarette Smoking Impact on Oral Health: A Case-Control Study
por: Suchanecka, Aleksandra, et al.
Publicado: (2020)

The Ankyrin Repeat and Kinase Domain Containing 1 Gene Polymorphism (ANKK1 Taq1A) and Personality Traits in Addicted Subjects
por: Grzywacz, Anna, et al.
Publicado: (2019)

Methylation in the Promoter Region of the Dopamine Transporter DAT1 Gene in People Addicted to Nicotine
por: Chmielowiec, Jolanta, et al.
Publicado: (2022)

Dopamine Receptor DRD2 Gene rs1076560, Personality Traits and Anxiety in the Polysubstance Use Disorder
por: Suchanecka, Aleksandra, et al.
Publicado: (2020)

Association between Polymorphism rs1799732 of DRD2 Dopamine Receptor Gene and Personality Traits among MMA Athletes
por: Niewczas, Marta, et al.
Publicado: (2021)

Analysis of DRD2 Gene Polymorphism in the Context of Personality Traits in a Group of Athletes
por: Chmielowiec, Krzysztof, et al.
Publicado: (2021)

Contribution of Dopamine Transporter Gene Methylation Status to Cannabis Dependency
por: Grzywacz, Anna, et al.
Publicado: (2020)

Analysis of Selected Variants of DRD2 and ANKK1 Genes in Combat Athletes
por: Michałowska-Sawczyn, Monika, et al.
Publicado: (2021)

Genetic Factors of Teeth Impaction: Polymorphic and Haplotype Variants of PAX9, MSX1, AXIN2, and IRF6 Genes
por: Trybek, Grzegorz, et al.
Publicado: (2023)

Association of Polymorphism CHRNA5 and CHRNA3 Gene in People Addicted to Nicotine
por: Chmielowiec, Krzysztof, et al.
Publicado: (2022)

Association Between the rs4680 Polymorphism of the COMT Gene and Personality Traits among Combat Sports Athletes
por: Humińska-Lisowska, Kinga, et al.
Publicado: (2023)

The Dynamic Environment of Crypto Markets: The Lifespan of New Psychoactive Substances (NPS) and Vendors Selling NPS
por: Wadsworth, Elle, et al.
Publicado: (2018)

Mechanistic Insights into the Stimulant Properties of Novel Psychoactive Substances (NPS) and Their Discrimination by the Dopamine Transporter—In Silico and In Vitro Exploration of Dissociative Diarylethylamines
por: Sahai, Michelle A., et al.
Publicado: (2018)

An Expanding World of Novel Psychoactive Substances: Opioids
por: Zawilska, Jolanta B.
Publicado: (2017)

Novel Psychoactive Substances (NPS): a Study on Persian Language Websites
por: BIGDELI, Imanollah, et al.
Publicado: (2013)

Associations between the dopamine D4 receptor gene polymorphisms and personality traits in elite athletes
por: Michałowska-Sawczyn, Monika, et al.
Publicado: (2019)

The Role of Dopamine in the Stimulant Characteristics of Novel Psychoactive Substances (NPS)—Neurobiological and Computational Assessment Using the Case of Desoxypipradrol (2-DPMP)
por: Loi, Barbara, et al.
Publicado: (2020)

Clinical Presentations and Predictors of In-Hospital Mortality in Illicit Drug Users in the New Psychoactive Substances (NPS) Endemic Era in Taiwan
por: Yeh, Hsin-Tzu, et al.
Publicado: (2022)

Suicidality and self-injury behaviours due to the use of Novel Psychoactive Substances (NPS)
por: Orsolini, L.
Publicado: (2023)

Molecular Mechanisms of Action of Novel Psychoactive Substances (NPS). A New Threat for Young Drug Users with Forensic-Toxicological Implications
por: Giorgetti, Arianna, et al.
Publicado: (2021)

Hair analysis for New Psychoactive Substances (NPS): Still far from becoming the tool to study NPS spread in the community?
por: Florou, Dimitra, et al.
Publicado: (2021)

Abuse of Prescription Drugs in the Context of Novel Psychoactive Substances (NPS): A Systematic Review
por: Schifano, Fabrizio, et al.
Publicado: (2018)

Recent Changes in Drug Abuse Scenarios: The New/Novel Psychoactive Substances (NPS) Phenomenon
por: Schifano, Fabrizio
Publicado: (2018)

Prevalence of Novel Psychoactive Substance (NPS) Use in Patients Admitted to Drug Detoxification Treatment
por: Specka, Michael, et al.
Publicado: (2020)

Sales and Advertising Channels of New Psychoactive Substances (NPS): Internet, Social Networks, and Smartphone Apps
por: Miliano, Cristina, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_ikp53b70erds29vvrnjsbk4dhb